Promising COVID-19 therapeutic drug to start phase 3 clinical trial in the United States

Recruitment of first US-based patients in Dapsone trial has started.

Related Keywords

United States ,Canada ,North Carolina ,Idaho ,Washington ,Canadian ,Jean Bourbeau ,Principal Research Solutions ,Mcconnell Centre For Innovative Medicine ,Mcgill University Health Centre Foundation ,Translational Research In Respiratory Diseases Program ,Mcgill University ,Peters Medical Research ,Translational Research ,Respiratory Diseases Program ,Research Institute ,Mcgill University Health Centre ,Mcconnell Centre ,Health Canada Approved ,Principal Research ,